Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 28,460 shares at $7.01 ($199K) on 2017-02-28, disclosed to the SEC on 2017-03-01.
Open-market sale of $199k STML by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.97 | 7,500 | $52K | 26.2% |
| 2 | $7.01 | 10,480 | $73K | 36.9% |
| 3 | $7.01 | 10,480 | $73K | 36.9% |
| Total | $7.00 avg | 28,460 | $199K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |